Skip to main content
. 2020 Apr 25;20:352. doi: 10.1186/s12913-020-05195-5

Table 3.

The proportion of patients who were dispensed benzodiazepines, z-hypnotics, and gabapentinoids, respectively

Year 2013 2014 2015 2016 2017
Benzodiazepines or z-hypnotics No. %a No. %a No. %a No. %a No. %a
 Oxazepam 2094 28 2091 27 2124 27 2183 28 2229 29
 Diazepam 1216 16 1251 16 1222 16 1272 17 1289 17
 Zopiclone 1026 14 964 12 932 12 936 12 863 11
 Nitrazepam 757 10 759 10 747 10 737 10 701 9
 Clonazepam 479 6 432 6 362 5 331 4 268 4
 Zolpidem 351 5 359 5 333 4 315 4 327 4
 Alprazolam 305 4 304 4 237 3 206 3 196 3
 Flunitrazepam 41 1 38 0 37 0 32 0 36 0
Gabapentinoids No. %a No. %a No. %a No. %a No. %a
 Pregabalin 487 6 449 6 491 6 523 7 591 8
 Gabapentin 260 3 240 3 277 4 291 4 310 4

No. Number of patients, OAT Opioid agonist therapy

aPercent of all patients who were dispensed an OAT opioid

The table displays the proportion of all OAT patients who were dispensed different benzodiazepines, z-hypnotics, and gabapentinoids